Abattis Bioceuticals (STU:115) Total Long-Term Liabilities : €2.52 Mil (As of Sep. 2019)

View and export this data going back to 2014. Start your Free Trial

What is Abattis Bioceuticals Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Abattis Bioceuticals's Total Long-Term Liabilities for the quarter that ended in Sep. 2019 was €2.52 Mil.

Abattis Bioceuticals Total Long-Term Liabilities Historical Data

The historical data trend for Abattis Bioceuticals's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Total Long-Term Liabilities Chart

Abattis Bioceuticals Annual Data

Trend

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Total Long-Term Liabilities

Get a 7-Day Free Trial

0.02

2.52

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Total Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	2.44	2.52

Abattis Bioceuticals Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Abattis Bioceuticals Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Abattis Bioceuticals (STU:115) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (STU:115) » Definitions » Total Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6

Website

http://www.abattis.com

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.

Abattis Bioceuticals (STU:115) Headlines

No Headlines